160 related articles for article (PubMed ID: 10070023)
1. Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes.
Mamotte CD; Sturm M; Foo JI; van Bockxmeer FM; Taylor RR
Am J Physiol; 1999 Mar; 276(3):E553-7. PubMed ID: 10070023
[TBL] [Abstract][Full Text] [Related]
2. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
Dergunov AD; Novoselov AV; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888
[TBL] [Abstract][Full Text] [Related]
3. Abnormal in vivo metabolism of apolipoprotein E4 in humans.
Gregg RE; Zech LA; Schaefer EJ; Stark D; Wilson D; Brewer HB
J Clin Invest; 1986 Sep; 78(3):815-21. PubMed ID: 3745440
[TBL] [Abstract][Full Text] [Related]
4. Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans.
Welty FK; Lichtenstein AH; Barrett PH; Jenner JL; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1807-10. PubMed ID: 10894821
[TBL] [Abstract][Full Text] [Related]
5. Very low density lipoprotein receptor binds apolipoprotein E2/2 as well as apolipoprotein E3/3.
Takahashi S; Oida K; Ookubo M; Suzuki J; Kohno M; Murase T; Yamamoto T; Nakai T
FEBS Lett; 1996 May; 386(2-3):197-200. PubMed ID: 8647281
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E polymorphism and the distribution profile of very low density lipoproteins; an influence of the E4 allele on large (Sf > 60) particles.
Bioletto S; Fontana P; Darioli R; James RW
Atherosclerosis; 1998 May; 138(1):207-15. PubMed ID: 9678786
[TBL] [Abstract][Full Text] [Related]
7. Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects.
Demant T; Bedford D; Packard CJ; Shepherd J
J Clin Invest; 1991 Nov; 88(5):1490-501. PubMed ID: 1939641
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro.
Nathan BP; Bellosta S; Sanan DA; Weisgraber KH; Mahley RW; Pitas RE
Science; 1994 May; 264(5160):850-2. PubMed ID: 8171342
[TBL] [Abstract][Full Text] [Related]
9. Enhanced metabolism of normolipidemic human plasma very low density lipoprotein in cultured cells by exogenous apolipoprotein E-3.
Eisenberg S; Friedman G; Vogel T
Arteriosclerosis; 1988; 8(5):480-7. PubMed ID: 3190555
[TBL] [Abstract][Full Text] [Related]
10. Studies on the binding and degradation of human very-low-density lipoproteins by human hepatoma cell line HepG2.
Dashti N; Wolfbauer G
Biochim Biophys Acta; 1986 Feb; 875(3):473-86. PubMed ID: 3004589
[TBL] [Abstract][Full Text] [Related]
11. Conformation of apolipoprotein E both in free and in lipid-bound form may determine the avidity of triglyceride-rich lipoproteins to the LDL receptor: structural and kinetic study.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):14-28. PubMed ID: 10685027
[TBL] [Abstract][Full Text] [Related]
12. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth.
Bellosta S; Nathan BP; Orth M; Dong LM; Mahley RW; Pitas RE
J Biol Chem; 1995 Nov; 270(45):27063-71. PubMed ID: 7592957
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112.
Weisgraber KH
J Lipid Res; 1990 Aug; 31(8):1503-11. PubMed ID: 2280190
[TBL] [Abstract][Full Text] [Related]
14. High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).
Chappell DA
J Clin Invest; 1989 Dec; 84(6):1906-15. PubMed ID: 2556448
[TBL] [Abstract][Full Text] [Related]
15. Defective VLDL metabolism and severe atherosclerosis in mice expressing human apolipoprotein E isoforms but lacking the LDL receptor.
Knouff C; Briand O; Lestavel S; Clavey V; Altenburg M; Maeda N
Biochim Biophys Acta; 2004 Aug; 1684(1-3):8-17. PubMed ID: 15450205
[TBL] [Abstract][Full Text] [Related]
16. Interaction of LpB, LpB:E, LpB:C-III, and LpB:C-III:E lipoproteins with the low density lipoprotein receptor of HeLa cells.
Agnani G; Bard JM; Candelier L; Delattre S; Fruchart JC; Clavey V
Arterioscler Thromb; 1991; 11(4):1021-9. PubMed ID: 2065026
[TBL] [Abstract][Full Text] [Related]
17. ApoE is necessary and sufficient for the binding of large triglyceride-rich lipoproteins to the LDL receptor; apoB is unnecessary.
Bradley WA; Gianturco SH
J Lipid Res; 1986 Jan; 27(1):40-8. PubMed ID: 3958613
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis for the differences in lipid and lipoprotein binding properties of human apolipoproteins E3 and E4.
Nguyen D; Dhanasekaran P; Nickel M; Nakatani R; Saito H; Phillips MC; Lund-Katz S
Biochemistry; 2010 Dec; 49(51):10881-9. PubMed ID: 21114327
[TBL] [Abstract][Full Text] [Related]
19. Human apolipoprotein E7:lysine mutations in the carboxy-terminal domain are directly responsible for preferential binding to very low density lipoproteins.
Dong J; Balestra ME; Newhouse YM; Weisgraber KH
J Lipid Res; 2000 Nov; 41(11):1783-9. PubMed ID: 11060347
[TBL] [Abstract][Full Text] [Related]
20. Reversal of hypercholesterolemia in apolipoprotein E2 and apolipoprotein E3-Leiden transgenic mice by adenovirus-mediated gene transfer of the VLDL receptor.
van Dijk KW; van Vlijmen BJ; van der Zee A; van't Hof B; van der Boom H; Kobayashi K; Chan L; Havekes LM; Hofker MH
Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):7-12. PubMed ID: 9445249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
